Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure

Postgraduate Medical Journal

Volumn 78, Issue 926, 2002, Pages 752-754

  Abraham, P ^a   Ralston, S H ^a   Hewison, M ^b   Fraser, W D ^c   Bevan, J S ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HYPERCALCEMIA; KIDNEY FAILURE; LAPAROTOMY; MEASUREMENT; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PARATHYROID HORMONE BLOOD LEVEL; PREECLAMPSIA; SPLENECTOMY; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; HYPERCALCEMIA; KIDNEY FAILURE, ACUTE; NEOPLASM PROTEINS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE HORMONES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 0036940442     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.926.752     Document Type: Article

References (18)

1. Kelly TR. Primary hyperparathyroidism during pregnancy. Surgery 1991;110:1028-33.
2. Kleinman GE, Rodriquez H, Good MC, et al. Hypercalcemic crisis in pregnancy associated with excessive ingestion of calcium carbonate antacid (milk-alkali syndrome): Successful treatment with hemodialysis. Obstet Gynecol 1991;78(3 pt 2):496-9.
3. Montoro MN, Paler RJ, Goodwin TM, et al. Parathyroid carcinoma during pregnancy. Obstet Gynecol 2000;96(5 pt 2):841.
4. Suva LJ, Winslow GA, Wettenhall RE, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression. Science 1987;237:893-6.
5. Ralston SH, Boyce BF, Cowan RA, et al. Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy. J Bone Miner Res 1989;4:103-11.
6. Ardawi MS, Nasrat HA, BA'Aqueel HS. Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: A longitudinal study. Eur J Endocrinol 1997;137:402-9.
7. Martin TJ, Suva LJ. Parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol (Oxf) 1989;31:631-47.
8. Ralston SH, Cowan RA, Robertson AG, et al. Circulating vitamin D metabolites and hypercalcaemia of malignancy. Acta Endocrinol (Copenh) 1984;106:556-63.
9. Schilling T, Pecherstorfer M, Blind E, et al. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab 1993;76:801-3.
10. Stewart AF, Horst R, Deftos LJ, et al. Biochemical evaluation of patients with cancer-associated hypercalcemia: Evidence for humoral and nonhumoral groups. N Engl J Med 1980;303:1377-83.
11. Broadus AE, Mangin M, Ikeda K, et al. Humoral hypercalcemia of cancer. Identification of a novel parothyroid hormone-like peptide. N Engl J Med 1988;319:556-63.
12. Schweitzer DH, Hamdy NA, Frolich M, et al. Malignancy-associated hypercalcaemia: Resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome. Clin Endocrinol (Oxf) 1994;41:251-6.
13. Sato H, Takahashi M. Non-Hodgkin's malignant lymphoma of the bone with intracavitary cardiac involvement. Intern Med 1993;32:502-7.
14. Gkonos PJ, Hayes T, Burtis W, et al. Squamous carcinoma model of humoral hypercalcemia of malignancy. Endocrinology 1984;115:2384-90.
15. Insogna KL, Stewart AF, Vignery AM, et al. Biochemical and histomorphometric charocterization of a rot model for humoral hypercalcemio of malignancy. Endocrinology 1984;114:888-96.
16. Shaker JL, Krawczyk KW, Findling JW. Primary hyperparathyroidism and severe hypercalcemia with low circulating 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 1990;71:1305-9.
17. Barhoum M, Hutchins L, Fonseca VA. Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide ond interleukin-6: Response to octreotide. Am J Med Sci 1999;318:203-5.
18. Mantzoros CS, Suva LJ, Moses AC, et al. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour. Clin Endocrinol (Oxf) 1997;46:373-5.